Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYO1D |
| Upstream (Parents) |
|---|
| (<<) GPA33 → MYO1D |
| (<<) HEPH → MYO1D |
| (<<) VDR → MYO1D |
| (<<) CD9 → MYO1D |
| Downstream (Children) |
|---|
| MYO1D → AXIN1 (>>) |
| MYO1D → GRM8 (>>) |
| MYO1D → MS4A12 (>>) |
| MYO1D → TUBAL3 (>>) |
| MYO1D → L3MBTL (>>) |
| MYO1D → PAX8 (>>) |
| MYO1D → CDC42EP4 (>>) |
| MYO1D → HS3ST3B1 (>>) |
| MYO1D → RLN1 (>>) |
| MYO1D → ZBTB7A (>>) |
| MYO1D → FRY (>>) |
